Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Keytruda and Monoclonal Antibodies in Advanced Cancer
NCT02318901Phase 2Terminated
- Sponsor
- Western Regional Medical Center
- Start
- Oct 2014
- Primary completion
- Aug 2018
- Countries
- 1
01
Overview
A Phase 2 trial of pembrolizumab in cancer, breast cancer, gastric cancer (GC), esophageal cancer, colorectal cancer (CRC), sponsored by Western Regional Medical Center. Started Oct 2014; status: terminated.
02
Drugs
03
Conditions
cancerbreast cancergastric cancer (GC)esophageal cancercolorectal cancer (CRC)
Beyond the preview
Go deeper on NCT02318901.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02318901.